Koyfin Home > Directory > Health Care > Boston Scientific Corp > Long-Term Debt / Capital

Boston Scientific Corp Long-Term Debt / Capital Chart (BSX)

Boston Scientific Corp annual/quarterly Long-Term Debt / Capital from 2010 to 2020.
  • Boston Scientific Corp Long-Term Debt / Capital for the quarter ending September 09, 2020 was $38m a 3.90% increase of 1m year over year
  • Boston Scientific Corp Long-Term Debt / Capital for the last 12 months ending September 09, 2020 was $38m a 3.90% increase of 1m year over year
  • Boston Scientific Corp Annual Long-Term Debt / Capital for 2019 was $37m a 17.09% increase of 6m from 2018
  • Boston Scientific Corp Annual Long-Term Debt / Capital for 2018 was $30m a 0.46% increase of 0m from 2017
  • Boston Scientific Corp Annual Long-Term Debt / Capital for 2017 was $30m a -46.85% decrease of -14m from 2016
Other Ratios Metrics:
  • Boston Scientific Corp Total Debt / Capital for the quarter ending December 12, 2018 was $44m a -1.42% decrease of -1m year over year
  • Boston Scientific Corp Other Liabilities for the quarter ending September 09, 2018 was $2,202m a -16.30% decrease of -359m year over year
  • Boston Scientific Corp Total Debt / Equity for the quarter ending December 12, 2018 was $80m a -2.59% decrease of -2m year over year
View Chart On Koyfin

Quarterly BSX Long-Term Debt / Capital Data

09/2020$38m
06/2020$38m
03/2020$39m
12/2019$37m
09/2019$47m
06/2019$41m
03/2019$42m
12/2018$30m
09/2018$32m
06/2018$34m

Annual BSX Long-Term Debt / Capital Data

2019$37m
2018$30m
2017$30m
2016$44m
2015$47m
2014$36m
2013$39m
2012$38m
2011$27m
2010$29m